YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ken W who wrote (2902)	8/30/2003 11:04:11 AM
From: Sergio H	Read Replies (1) of 23958

Good Morning Ken. Went to pick up Freebird (and his laundry) last night for the long weekend. He's already a changed man. <ggg> Really. He's learned to accentuate the positive. Today's Barron's pans BLTI: <Biolase's shares, much like its product, are rather pricey. It trades at 44 times estimated earnings for this year -- well above the 31.5 multiple of medical-technology companies in general and the 19 multiple of the Standard & Poor's 500 index.> Barron's conclusion won't help the stock on Tues.: <For the millions of Americans who dread visiting the dentist, no-pain technology is clearly something to smile about. But unless it takes hold, betting on Biolase could be just as painful as an old-fashioned root canal.> I am intrigued by the increase in FAME's short position, as posted by Joe S. Haven't found anything yet. I like the deal.com site for this type of info, but I think that PERF's merger is too small for this site. Anyway, there's some good info at this site and it illustrates arbitrage on mergers activity for anyone interested. thedeal.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next